The real signal from Home Care 100 wasn’t about technology — it was about clarity.
At this year’s Home Care 100 (HC 100), conversations with home health and hospice leaders shared a common theme: the industry isn’t lacking tools. It’s struggling with fragmentation, cognitive load, and execution across an increasingly complex care journey.
What stood out most wasn’t any single product category or buzzword — it was a collective shift in how leaders are evaluating technology decisions heading into 2026.
Here are the signals we heard consistently:
Interoperability is no longer optional
Leaders are under pressure to connect intake, clinical insight, and downstream action — not manage them in silos. Fragmentation is now seen as a direct barrier to speed, scale, and margin.
What resonated most were platforms that reduce handoffs and allow teams to work from a shared understanding of the patient — rather than stitching together point solutions after the fact.
Automation is being redefined
There’s growing skepticism around automation that simply shifts work downstream.
Leaders want solutions that quietly absorb complexity — especially across referrals, OASIS, and coding — without introducing rework, exceptions, or additional cleanup for clinicians.
The bar is no longer “faster.”
It’s hands-free where possible, intentional where it matters.
Clinical intelligence needs to travel upstream
Agencies increasingly want to share meaningful clinical insight with physicians, ACOs, and payers — supporting better decisions earlier in the care journey.
This isn’t about reporting for reporting’s sake. It’s about using insight to:
- Strengthen referral relationships
- Support value-based arrangements
- Improve confidence at the point of care
End-to-end thinking is replacing point solutions
The strongest reactions came when conversations focused on the entire patient journey — from intake through outcomes — rather than isolated workflows.
Leaders are asking fewer “feature” questions and more strategic ones:
- How does this reduce friction across teams?
- How does insight turn into action?
- How does this scale as complexity increases?
A moment from HC 100
One of these themes came to life in a live HC 100 conversation between Mosai’s Chief Product Officer, Laura Brinkoetter, and Tom Maxwell.
They discussed how Mosai is bringing together interoperability and clinical analytics — and what “hands-free” automation actually looks like when applied to real-world workflows like OASIS reconciliation and clinical review.
